BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21877142)

  • 1. Tissue composition of mammographically dense and non-dense breast tissue.
    Ghosh K; Brandt KR; Reynolds C; Scott CG; Pankratz VS; Riehle DL; Lingle WL; Odogwu T; Radisky DC; Visscher DW; Ingle JN; Hartmann LC; Vachon CM
    Breast Cancer Res Treat; 2012 Jan; 131(1):267-75. PubMed ID: 21877142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase immunoreactivity is increased in mammographically dense regions of the breast.
    Vachon CM; Sasano H; Ghosh K; Brandt KR; Watson DA; Reynolds C; Lingle WL; Goss PE; Li R; Aiyar SE; Scott CG; Pankratz VS; Santen RJ; Ingle JN
    Breast Cancer Res Treat; 2011 Jan; 125(1):243-52. PubMed ID: 20526739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues.
    Gabrielson M; Chiesa F; Paulsson J; Strell C; Behmer C; Rönnow K; Czene K; Östman A; Hall P
    Breast Cancer Res Treat; 2016 Jul; 158(2):253-61. PubMed ID: 27349429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline breast tissue characteristics determine the effect of tamoxifen on mammographic density change.
    Gabrielson M; Hammarström M; Bergqvist J; Lång K; Rosendahl AH; Borgquist S; Hellgren R; Czene K; Hall P
    Int J Cancer; 2024 Jul; 155(2):339-351. PubMed ID: 38554131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-based associations of mammographic breast density with breast stem cell markers.
    Yaghjyan L; Stoll E; Ghosh K; Scott CG; Jensen MR; Brandt KR; Visscher D; Vachon CM
    Breast Cancer Res; 2017 Aug; 19(1):100. PubMed ID: 28851411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(1):57-63. PubMed ID: 23613389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study.
    Conroy SM; Pagano I; Kolonel LN; Maskarinec G
    Cancer Epidemiol; 2011 Oct; 35(5):448-52. PubMed ID: 21247819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of breast density on the presenting features of malignancy.
    Arora N; King TA; Jacks LM; Stempel MM; Patil S; Morris E; Morrow M
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():211-8. PubMed ID: 20853035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.
    Huo CW; Chew G; Hill P; Huang D; Ingman W; Hodson L; Brown KA; Magenau A; Allam AH; McGhee E; Timpson P; Henderson MA; Thompson EW; Britt K
    Breast Cancer Res; 2015 Jun; 17(1):79. PubMed ID: 26040322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There a Correlation between the Presence of a Spiculated Mass on Mammogram and Luminal A Subtype Breast Cancer?
    Liu S; Wu XD; Xu WJ; Lin Q; Liu XJ; Li Y
    Korean J Radiol; 2016; 17(6):846-852. PubMed ID: 27833400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast-specific gamma imaging or ultrasonography as adjunct imaging diagnostics in women with mammographically dense breasts.
    Zhang Z; Wang W; Wang X; Yu X; Zhu Y; Zhan H; Chen Z; Li B; Huang J
    Eur Radiol; 2020 Nov; 30(11):6062-6071. PubMed ID: 32524221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of breast cancers detected by ultrasound screening in women with negative mammograms.
    Bae MS; Han W; Koo HR; Cho N; Chang JM; Yi A; Park IA; Noh DY; Choi WS; Moon WK
    Cancer Sci; 2011 Oct; 102(10):1862-7. PubMed ID: 21752153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-palpable breast carcinomas: correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors.
    Karamouzis MV; Likaki-Karatza E; Ravazoula P; Badra FA; Koukouras D; Tzorakoleftherakis E; Papavassiliou AG; Kalofonos HP
    Int J Cancer; 2002 Nov; 102(1):86-90. PubMed ID: 12353238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer detection using sonography in women with mammographically dense breasts.
    Okello J; Kisembo H; Bugeza S; Galukande M
    BMC Med Imaging; 2014 Dec; 14():41. PubMed ID: 25547239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic density, response to hormones, and breast cancer risk.
    Boyd NF; Melnichouk O; Martin LJ; Hislop G; Chiarelli AM; Yaffe MJ; Minkin S
    J Clin Oncol; 2011 Aug; 29(22):2985-92. PubMed ID: 21709206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(2):366-71. PubMed ID: 23818347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.
    Ding Y; Ding K; Qian H; Yu X; Zou D; Yang H; Mo W; He X; Zhang F; Qin C; Zheng Y; Ding X
    PLoS One; 2020; 15(4):e0231895. PubMed ID: 32298374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.
    Rhodes DJ; Hruska CB; Conners AL; Tortorelli CL; Maxwell RW; Jones KN; Toledano AY; O'Connor MK
    AJR Am J Roentgenol; 2015 Feb; 204(2):241-51. PubMed ID: 25615744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenchymal pattern in women with dense breasts. Variation with age and impact on screening outcomes: observations from a UK screening programme.
    Ward L; Heller S; Hudson S; Wilkinson L
    Eur Radiol; 2018 Nov; 28(11):4717-4724. PubMed ID: 29808426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density.
    Lundström E; Sahlin L; Skoog L; Hägerström T; Svane G; Azavedo E; Sandelin K; von Schoultz B
    Climacteric; 2006 Aug; 9(4):277-82. PubMed ID: 16857657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.